Abacus Global Management
ABX
8.33
+0.04
+0.48%
Abacus Global Management
US · ABX
#3407 by market cap
8.33
+0.04
+0.48%
Live - 5344 symbols - heartbeat 154s ago
· 2026-10-08 10:07
Pre-market
8.35
+0.72%
After-hours
8.29
0.00%
- Market cap
- 814.61M
- P/E (TTM)i
- 30.85
- P/Bi
- 1.87
- EPSi
- 0.36
- Div yieldi
- 2.40%
- 52W posi
- 46%
Reader sentiment
Are you bullish or bearish on ABX?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.41, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 6 years
Latest year +110.18% YoY
Margins
- Gross margin
- 87.73%
- Operating margin
- 36.30%
- Net margin
- 15.53%
Key ratios & quality
- Enterprise valuei
- 1.18B
- PEG ratioi
- 6.35
- Altman Z-Scorei
- 1.41
PEG uses trailing P/E against the 3-year net income growth rate (4.86%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Revenue | 1.22M | 22.59M | 44.71M | 66.40M | 111.92M | 235.24M |
| Gross profit | 710.01K | 8.39M | 38.83M | 59.91M | 100.55M | 206.38M |
| Selling & admin expenses | 47.99K | 7.44M | 4.02M | 31.39M | 90.80M | 102.38M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 662.02K | 937.12K | 34.80M | 25.11M | 1.84M | 85.40M |
| Pretax profit | 662.02K | 998.62K | 33.28M | 10.50M | -19.43M | 52.75M |
| Tax | -- | 1.20K | 889.94K | 1.47M | 5.48M | 15.43M |
| Net profit | 662.02K | 997.42K | 32.39M | 9.03M | -24.92M | 37.31M |
| Basic EPS | 0 | 0 | 1 | 0 | 0 | 0 |
| Diluted EPS | 0.01 | 0.02 | 0.63 | 0.16 | -0.34 | 0.36 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 44.14M | 56.22M | 62.98M | 71.90M | 59.39M | 73.02M |
| Gross profit | 37.03M | 50.17M | 55.32M | 63.86M | 53.08M | 63.96M |
| Selling & admin expenses | 14.88M | 22.19M | 28.51M | 36.80M | 30.82M | 38.51M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 17.39M | 22.79M | 22.41M | 22.80M | 18.33M | 21.48M |
| Pretax profit | 7.73M | 21.68M | 11.77M | 11.56M | 11.06M | 10.98M |
| Tax | 2.33M | 4.07M | 4.69M | 4.34M | 3.79M | 4.35M |
| Net profit | 5.40M | 17.61M | 7.08M | 7.23M | 7.27M | 6.63M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.05 | 0.18 | 0.07 | 0.06 | 0.07 | 0.07 |
Balance sheet
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Total current assets | 211.20K | 3.54M | 33.28M | 31.78M | 159.56M | 69.57M |
| Cash & ST investments | 135.27K | 2.60M | 30.05M | 27.84M | 131.94M | 38.11M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 1.46M | 5.29M | 59.09M | 331.83M | 874.16M | 902.24M |
| Total current liabilities | 160.70K | 2.34M | 1.30M | 23.33M | 62.47M | 148.59M |
| Short-term debt | -- | 135.32K | 48.13K | 13.15M | 38.95M | 116.64M |
| Long-term debt | -- | -- | 28.25M | 126.79M | 342.39M | 289.89M |
| Total liabilities | 160,696.00 | 2,569,002.00 | 30,945,150.00 | 167,755,991.00 | 450,870,080.00 | 483,699,328.00 |
| Total equity | 1.30M | 2.72M | 28.15M | 164.07M | 423.29M | 418.54M |
| Retained earnings | -- | -- | 25.49M | -34.73M | -57.90M | -41.63M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 61.46M | 105.92M | 138.15M | 69.57M | 68.32M | 64.64M |
| Cash & ST investments | 43.76M | 74.84M | 86.42M | 38.11M | 37.21M | 23.39M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 856.51M | 848.36M | 918.94M | 902.24M | 829.79M | 867.73M |
| Total current liabilities | 130.80M | 140.18M | 148.44M | 148.59M | 35.80M | 91.74M |
| Short-term debt | 118.61M | 119.52M | 120.17M | 116.64M | 2.83M | 42.42M |
| Long-term debt | 237.97M | 238.19M | 289.77M | 289.89M | 328.50M | 290.82M |
| Total liabilities | 425,930,259.00 | 431,824,728.00 | 484,343,537.00 | 483,699,328.00 | 412,191,800.00 | 433,052,994.00 |
| Total equity | 430.58M | 416.53M | 434.59M | 418.54M | 417.60M | 434.68M |
| Retained earnings | -53.26M | -35.77M | -28.86M | -41.63M | -34.46M | -27.93M |
Cash flow
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | 650.14K | 1.34M | 10.69M | -64.04M | -208.81M | -25.68M |
| Depreciation & amortization | 0 | 31.24K | 4.28K | 3.41M | 7.91M | 18.61M |
| Free cash flow | 650.14K | 1.12M | 10.69M | -64.23M | -209.62M | -26.61M |
| Dividends paid | -- | -358.22K | -- | -- | 0 | -19.84M |
| Stock buybacks / issuance | -- | -- | -6.40M | -23.84M | 170.96M | -43.78M |
| Ending cash balance | 135.27K | 2.60M | 30.05M | 25.59M | 131.94M | 38.11M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | -61.59M | 76.10M | -32.75M | -7.44M | 91.69M | 39.26M |
| Depreciation & amortization | 4.76M | 5.18M | 4.40M | 4.26M | 3.93M | 3.96M |
| Free cash flow | -61.83M | 75.69M | -32.92M | -7.55M | 90.80M | 38.11M |
| Dividends paid | 0 | 0 | -93.75K | -19.74M | -93.75K | -93.75K |
| Stock buybacks / issuance | 0 | -35.05M | -3.19M | -5.54M | -14.45M | -9.91M |
| Ending cash balance | 43.76M | 74.84M | 86.42M | 38.11M | 37.21M | 23.39M |
Returns & efficiency
| Line item | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|
| ROE %i | 50.91 | 1.31 | -3.59 | 11.47 | -8.15 | 8.67 |
| ROA %i | 45.31 | 0.88 | -2.08 | 5.68 | -3.97 | 4.11 |
| ROIC %i | 50.91 | 1.22 | -2.82 | 11.36 | -2.05 | 7.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | 62.74 | 54.29 |
| EBIT margin %i | 54.06 | -11.13 | -0.17 | 30.68 | -1.03 | 38.91 |
| FCF / sales %i | 53.09 | -- | -- | -- | -- | -- |
| Current ratioi | 1.31 | 1.51 | 25.55 | 1.36 | 2.55 | 0.47 |
| Quick ratioi | 1.31 | 1.38 | 25.47 | 1.33 | 2.51 | 0.44 |
| Debt / assetsi | 0.00 | 6.94 | 47.93 | 42.71 | 44.15 | 45.57 |
| LT debt / equityi | -- | 8.53 | 103.78 | 78.44 | 81.80 | 70.37 |
| Interest coveragei | -- | -- | -4.72 | 2.06 | -0.06 | 2.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | 278.49 | 70.47 | 73.92 |
| Net income CAGR (3Y) %i | -- | -- | -- | 143.15 | -- | 4.86 |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | -6.03 | -0.34 | 3.19 | 8.67 | 9.23 | 6.62 |
| ROA %i | -2.91 | -0.17 | 1.58 | 4.11 | 4.64 | 3.29 |
| ROIC %i | -0.23 | 3.00 | 5.42 | 7.47 | 8.32 | 6.51 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.38 | 22.34 | 29.99 | 38.91 | 38.21 | 31.63 |
| FCF / sales %i | -- | -- | -- | -- | 50.31 | 33.09 |
| Current ratioi | 0.47 | 0.76 | 0.93 | 0.47 | 1.91 | 0.70 |
| Quick ratioi | 0.46 | 0.72 | 0.90 | 0.44 | 1.76 | 0.66 |
| Debt / assetsi | 42.15 | 42.72 | 45.10 | 45.57 | 41.13 | 39.68 |
| LT debt / equityi | 56.29 | 58.31 | 67.72 | 70.37 | 81.05 | 69.45 |
| Interest coveragei | 0.52 | 1.27 | 1.74 | 2.36 | 2.41 | 2.16 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Life solutions is the largest reported line at 89.60% of revenue, across 3 reported segments.
- The next-largest line, Asset Management, is a distant second at 9.88% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Life solutions89.60%
Asset Management9.88%
Technology services0.52%
Quote time 2026-10-08 10:07:00 · For reference only, not investment advice and not tailored to your situation.